Official File : Novartis Complaint

Overview:

This is the official filed action against Novartis Pharmaceutical Corporation for violating a whistleblower's rights under the New Jersey Conscientious Employee Protection Act and retaliating against him for refusing to participate in illegal and unethical activities regarding the testing and reporting of human drug study results concerning Novartis' new cancer drug, Tasigna.

Click below to access this 14-page, 409KB complaint.

 | File Type: pdf

Find more white papers on Process OperationsQuality Assurance & ControlcGMPs

View all white papers»